Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


TSE CE Mark Process Simplified By EDQM Certification Of Suitability

This article was originally published in The Gray Sheet

Executive Summary

Manufacturers that have devices on the European market utilizing tissue derived from certain animals must have a TSE CE mark certificate starting May 1

You may also be interested in...

EU Tissue Directive Tackles TSE Fears; Avian Product Oversight May Grow

The European Commission may curtail approvals of animal-derived materials that have good synthetic alternatives, according to Paul Brooks, assistant VP-product services for BSI, Inc

EU Tissue Laws: TSE Directive Issued, Industry Awaits Additional HTP Rules

European Union member states must adopt and publish the European Commission's new directive on medical devices using tissues of animal origin by Jan. 1, 2004

Biden Extends Helping Hand To Small US Manufacturers, Vendors With ‘Made In America’ EO

The president’s executive order aims to give smaller companies a leg up over foreign competitors, among other objectives.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts